Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vanguard Mega Cap Growth ETF (MGK) vs UnitedHealth Group Inc (UNH) Price & Performance

Vanguard Mega Cap Growth ETFTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Vanguard Mega Cap Growth ETF vs UnitedHealth Group Inc — how do they compare? Vanguard Mega Cap Growth ETF trades at $94.43 (market cap $33.70B), while UnitedHealth Group Inc trades at $379.6 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 9.9× Vanguard Mega Cap Growth ETF's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Vanguard Mega Cap Growth ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vanguard Mega Cap Growth ETF for 45 Days and UnitedHealth Group Inc for 97 Days on average.

MGKUNH
Market Cap
$33.70B$332.96B
Volume
1,362,0107,273,749
Sector
Broad Market / FactorHealth
52-Week High
$95.11$436.35
52-Week Low
$70.70$259.02
Typical Hold Time
45 Days97 Days
Enterprise Value
—$374.82B
Dividend Yield
—2.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vanguard Mega Cap Growth ETF

MGK trades at $94.92, down 0.2% on the day, with a bullish technical signal from moving averages but bearish momentum from oscillators. The ETF focuses on large-cap US growth stocks with heavy technology concentration, offering low 0.05% expense ratio exposure to companies like Nvidia, Apple, and Microsoft. Recent articles highlight its strong five-year performance and appeal for long-term growth investors seeking mega-cap stability.

MGK presents a compelling growth ETF option with concentrated mega-cap exposure, though its tech-heavy composition increases sector-specific risk. The fund's low costs and historical outperformance make it suitable for investors with higher risk tolerance, while current technical indicators suggest potential near-term consolidation after recent gains.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $375.98, showing minor daily weakness but maintaining a bullish technical signal. The company reported strong Q2 2026 earnings, beating estimates, and reaffirmed its full-year outlook. Revenue growth remains robust, though net margins have compressed from prior years. Analyst sentiment is overwhelmingly positive, with a consensus price target of $473.89 implying significant upside.

The outlook for UNH is favorable, driven by earnings momentum and strategic initiatives like AI investment. Key risks include regulatory pressures and medical cost trends. The stock presents a compelling opportunity for investors seeking exposure to a leading healthcare company with solid fundamentals and Wall Street support.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MGK

No sentiment data available yet.

UNH
71% Buy29% Sell
Avg holding period · 97 Days

Top news

Latest headlines on both assets

About Vanguard Mega Cap Growth ETF

MGK is an ETF that seeks to track the performance of the CRSP US Mega Cap Growth Index. It provides a low-cost, diversified exposure to the largest growth companies in the U.S. stock market. The fund is composed of mega-cap stocks that exhibit key growth factors, including high expected long-term earnings growth, high historical sales and earnings growth, and high return on assets. MGK is typically used by investors seeking long-term capital appreciation from market-leading firms.

Read more on MGK →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →